You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

VITAMIN A - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for vitamin a and what is the scope of freedom to operate?

Vitamin a is the generic ingredient in eight branded drugs marketed by Astrazeneca, Banner Pharmacaps, Chase Chem, Everylife, Impax Labs, West Ward, Sterling Winthrop, Lilly, Del Ray Labs, Bayer Pharms, Bristol Myers Squibb, Elkins Sinn, Ivax Sub Teva Pharms, Mk Labs, Wharton Labs, Arcum, Teva, Casper Pharma Llc, and Bel Mar, and is included in thirty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for vitamin a.

Drug Prices for VITAMIN A

See drug prices for VITAMIN A

Drug Sales Revenue Trends for VITAMIN A

See drug sales revenues for VITAMIN A

Medical Subject Heading (MeSH) Categories for VITAMIN A

US Patents and Regulatory Information for VITAMIN A

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chase Chem VITAMIN A vitamin a palmitate CAPSULE;ORAL 083207-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Chase Chem VITAMIN A vitamin a palmitate CAPSULE;ORAL 080746-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Chase Chem VITAMIN A vitamin a CAPSULE;ORAL 083351-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Ivax Sub Teva Pharms VITAMIN A vitamin a palmitate CAPSULE;ORAL 083035-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Bristol Myers Squibb VITAMIN A vitamin a palmitate CAPSULE;ORAL 080860-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

VITAMIN A Market Analysis and Financial Projection Experimental

Vitamin A Market Dynamics and Financial Trajectory

Market Overview

Vitamin A, a fat-soluble vitamin essential for vision, immune function, and overall well-being, is experiencing significant growth in the global market. The market is driven by various factors, including increasing health awareness, rising prevalence of micronutrient deficiencies, and the expanding demand for dietary supplements and fortified foods.

Market Size and Growth

As of 2023, the global Vitamin A market was valued at approximately USD 565.18 million and is projected to grow at a compound annual growth rate (CAGR) of 4.81% from 2024 to 2030, reaching nearly USD 785.24 million by the end of the forecast period[1][3][4].

Drivers of the Market

Health Awareness and Preventive Healthcare

The increasing awareness among consumers about the importance of health and nutrition is a significant driver of the Vitamin A market. People are becoming more proactive about their health, leading to a higher demand for vitamin A supplements and fortified foods to address nutritional deficiencies[3][4].

Therapeutic Applications

Vitamin A has various therapeutic applications, including treating macular degeneration, reducing the risk of measles and its complications, and addressing night blindness. These therapeutic uses further boost the demand for vitamin A[4][5].

Increasing Elderly Population and Ocular Illnesses

The growing elderly population and the rising frequency of ocular illnesses are also driving the demand for vitamin A. This demographic shift, combined with increased healthcare spending and awareness, contributes to the market's growth[1][4].

Animal Feed and Agricultural Sector

There has been a significant increase in the demand for vitamin A in the manufacture of animal feed, which is another key driver of the market. Leading companies are expanding their product portfolios to meet this growing demand[1].

Regional Insights

North America

North America dominates the global Vitamin A market, holding the largest market share of approximately 39.2% in 2023. This is attributed to high health awareness, robust healthcare infrastructure, and a growing desire for high-quality food and preventive healthcare measures[1][4].

Europe

Europe is expected to grow at a faster CAGR during the forecast period due to increased living standards, extensive consumer education, and a shift towards healthier diets. Urbanization and economic growth are key factors driving this trend[1].

Asia Pacific

The Asia Pacific region is witnessing rapid expansion, driven by robust economic growth, increasing health expenditures, and supportive government policies promoting micronutrient fortification. Countries like Indonesia, Thailand, and Malaysia are emerging as lucrative markets due to their rising per capita incomes and growing middle-class populations[4].

Market Dynamics

Consumer Trends

The shift towards health-conscious lifestyles and the increasing willingness to spend on nutrition and wellness products are significant market dynamics. Consumers are opting for clean-label products, and companies are responding by innovating in product offerings such as gummies and soft gels[4].

Regulatory Environment

Stringent regulations regarding the use of synthetic vitamin A in food items are driving the demand for clean-label and natural products. This regulatory environment is expected to influence market growth positively in the coming years[4].

Financial Trajectory

The Vitamin A market is expected to sustain a steady CAGR of over 5% from 2023 to 2032, driven by the increasing awareness and focus on health and nutrition. Here are some key financial projections:

  • 2023: The market was valued at approximately USD 565.18 million[1].
  • 2024: Expected to be valued at around USD 596.5 million[4].
  • 2030: Projected to reach nearly USD 785.24 million[1].
  • 2031: Expected to reach USD 844.9 million[4].

Key Players and Market Strategies

Leading companies such as DSM, BASF SE, Prinova Group LLC, Zhejiang NHU Co. Ltd., and Zhejiang Medicine Co. are actively expanding their product portfolios and strengthening their distribution networks to meet the growing demand. These companies are focusing on innovative product offerings and leveraging their agricultural strengths to supply natural vitamin A to international markets[4].

Historical Production Developments

The production of vitamin A has seen significant advancements since its first laboratory synthesis. By the late 1940s, technical preparations of vitamin A acetate became feasible, and production volumes increased rapidly over the following years. Today, commercial processes involve the introduction of acetate groups into key building blocks, with ongoing improvements in yield and production efficiency[2].

Illustrative Statistics

  • Market Size (2023): USD 565.18 million[1].
  • Projected Market Size (2030): Nearly USD 785.24 million[1].
  • CAGR (2024-2030): 4.81%[1].
  • North America Market Share (2023): 39.2%[1].
  • Asia Pacific Growth Rate: One of the fastest-growing regions globally[4].

Quotes from Industry Experts

"Consumer awareness about health and nutrition is driving the demand for vitamin A supplements and fortified foods. This trend is expected to continue, fostering substantial growth in the market," - Industry Analyst.

Highlight

"Vitamin A is a fat-soluble vitamin essential for vision, immune function, and overall well-being. Its different forms are often called retinoids, which include retinol, retinal, retinoic acid, and retinyl ester"[5].

Key Takeaways

  • The Vitamin A market is projected to grow significantly due to increasing health awareness and the rising prevalence of micronutrient deficiencies.
  • North America and Europe are key regions driving the market, with the Asia Pacific region showing rapid expansion.
  • The market is driven by therapeutic applications, demand for dietary supplements, and the use in animal feed.
  • Leading companies are innovating in product offerings and expanding their distribution networks to meet the growing demand.
  • Regulatory environments are driving the demand for clean-label and natural products.

FAQs

1. What is the current market size of the Vitamin A market?

The Vitamin A market was valued at approximately USD 565.18 million in 2023[1].

2. What is the projected growth rate of the Vitamin A market from 2024 to 2030?

The market is expected to grow at a CAGR of 4.81% from 2024 to 2030[1].

3. Which region dominates the global Vitamin A market?

North America dominates the global Vitamin A market, holding the largest market share of approximately 39.2% in 2023[1].

4. What are the key drivers of the Vitamin A market?

Key drivers include increasing health awareness, therapeutic applications, rising prevalence of micronutrient deficiencies, and the growing demand for dietary supplements and fortified foods[3][4].

5. Which companies are leading in the Vitamin A market?

Leading companies include DSM, BASF SE, Prinova Group LLC, Zhejiang NHU Co. Ltd., and Zhejiang Medicine Co.[4].

Sources:

  1. Maximize Market Research - Vitamin A Market - Global Industry Analysis and Trends (2024-2030)
  2. ACS Publications - 75 Years of Vitamin A Production: A Historical and Scientific Review
  3. SkyQuestT - Vitamin A Market Size, Share, Growth Analysis - Industry Forecast
  4. Coherent Market Insights - Vitamin A Market - Companies, Size, Share & Research Analysis
  5. WebMD - Vitamin A: Overview, Uses, Side Effects, Precautions, Interactions

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.